Clindamycin 600 mg Every 6 Hours for Serious Infections
Clindamycin 600 mg IV every 6 hours is an FDA-approved and guideline-supported regimen for serious anaerobic and Gram-positive infections in adults, providing adequate serum concentrations above the MIC for most susceptible organisms. 1
FDA-Approved Dosing for Serious Infections
The FDA label explicitly recommends 600 mg to 1,200 mg per day in 2,3, or 4 equal doses for serious infections due to aerobic Gram-positive cocci and susceptible anaerobes (excluding Bacteroides fragilis, Peptococcus species, and Clostridium species other than C. perfringens). 1
For more severe infections, particularly those involving proven or suspected B. fragilis, Peptococcus, or Clostridium species (other than C. perfringens), the FDA recommends 1,200 mg to 2,700 mg per day in 2,3, or 4 equal doses. 1
Serum concentrations can be maintained above the MIC for most indicated organisms by administering clindamycin every 8 to 12 hours in adults, though every 6-hour dosing is also explicitly approved. 1
Guideline Support for Necrotizing Infections
The 2014 IDSA skin and soft tissue infection guidelines recommend clindamycin 600–900 mg IV every 8 hours for necrotizing streptococcal infections (combined with penicillin) and for clostridial myonecrosis. 2
For necrotizing staphylococcal infections, the guidelines list clindamycin 600–900 mg IV every 8 hours as an alternative agent. 2
Pharmacokinetic Evidence Supporting Q6H vs Q8H Dosing
The choice between every 6-hour and every 8-hour dosing depends on the severity of infection and the MIC of the pathogen:
Pharmacokinetic studies demonstrate that 600 mg every 6 hours achieves mean peak concentrations of 16.8 mcg/mL and trough concentrations of 2.3 mcg/mL, maintaining levels above 2 mcg/mL throughout the dosing interval. 3
In contrast, 600 mg every 8 hours produces similar peak levels but lower trough concentrations (approximately 0.9–1.2 mcg/mL), with serum levels dropping below 2 mcg/mL for part of the dosing interval. 4, 5
A hospital-wide study comparing 600 mg every 6 hours versus every 8 hours found no difference in clinical efficacy (87% success rate in both groups) for routine infections, supporting the safety of less frequent dosing in many clinical scenarios. 6
When to Use 600 mg Every 6 Hours
The every 6-hour regimen is most appropriate for:
Life-threatening infections where maintaining consistently high serum concentrations is critical. 1
Infections caused by organisms with higher MICs (approaching the 0.25 mg/L EUCAST breakpoint for S. aureus), where trough concentrations must remain above twice the MIC. 7
Anaerobic lung infections, where clindamycin 600 mg IV every 6 hours has demonstrated superior efficacy compared to penicillin, particularly against penicillin-resistant Bacteroides melaninogenicus. 8
Practical Dosing Algorithm
For serious infections in adults:
Start with 600 mg IV every 8 hours for most serious infections (total daily dose 1,800 mg), as this is the most commonly recommended guideline regimen and provides adequate coverage for susceptible organisms. 2, 1
Escalate to 600 mg IV every 6 hours (total daily dose 2,400 mg) for:
Consider 900 mg every 8 hours (total daily dose 2,700 mg) as an alternative to every 6-hour dosing, as this provides similar peak and trough concentrations with less frequent administration. 4, 5
Important Caveats
Single IM injections should not exceed 600 mg due to local tolerability concerns. 1
Infusion rates should not exceed 30 mg per minute, and concentrations in diluent should not exceed 18 mg/mL. 1
Monitor for Clostridioides difficile infection, as clindamycin carries a black box warning for antibiotic-associated colitis; discontinue immediately if diarrhea develops. 1
No dose adjustment is needed for renal or hepatic impairment, as clindamycin pharmacokinetics are minimally affected by organ dysfunction. 1
When combined with rifampicin, clindamycin clearance increases threefold, requiring doses of at least 3,600–4,800 mg/day by continuous infusion to maintain therapeutic levels. 7